Yeji
NDA/BLA filedconf 0.95

axs-07 — NDA/BLA filed

$AXSM · Axsome Therapeutics, Inc. · acute treatment of migraine
Event date
Date TBD
Sponsor runway
44 mo
$305.1M liquid

Evidence

“the U.S. Food and Drug Administration has accepted for filing the Company's New Drug Application for AXS-07 for the acute treatment of migraine.”
Source: 8-K filed 2021-09-14View on EDGAR ↗0001193125-21-272174

Comparable historical nda/bla fileds· last 5 years · same indication

TickerDrugDateOutcome
$AXSMaxs-072024-09-04unknown

Recent insider activity· ±90 days

5 insiders · 0 buys · 3 sells
Exercise10b5-1
2026-05-05
Jacobson Mark L.
Chief Operating Officer
233 @ $12.95$3K
Sell10b5-1
2026-05-05
Jacobson Mark L.
Chief Operating Officer
233 @ $228.18$53K
Sell10b5-1
2026-05-04
Jacobson Mark L.
Chief Operating Officer
4,517 @ $227.94$1.03M
Exercise10b5-1
2026-05-04
Jacobson Mark L.
Chief Operating Officer
4,517 @ $12.95$58K
Exercise10b5-1
2026-04-22
Maizel Ari
Chief Commercial Officer
7,500 @ $70.73$530K
Sell10b5-1
2026-04-22
Maizel Ari
Chief Commercial Officer
7,500 @ $182.42$1.37M
Grant
2026-04-21
TABUTEAU HERRIOT
Chief Executive Officer
24,081 @ ——
Grant
2026-04-21
Maizel Ari
Chief Commercial Officer
7,224 @ ——
Grant
2026-04-21
Jacobson Mark L.
Chief Operating Officer
8,669 @ ——
Grant
2026-04-21
Murdock Hunter R.
General Counsel
7,224 @ ——
Grant
2026-04-21
Pizzie Nick
Chief Financial Officer
8,188 @ ——
← All catalysts for $AXSM